Undetectable gadolinium brain retention in individuals with an age-dependent blood-brain barrier breakdown in the hippocampus and mild cognitive impairment.
Alzheimers Dement
; 15(12): 1568-1575, 2019 12.
Article
in En
| MEDLINE
| ID: mdl-31862169
ABSTRACT
INTRODUCTION:
Blood-brain barrier (BBB) breakdown is an early independent biomarker of human cognitive dysfunction, as found using gadolinium (Gd) as a contrast agent. Whether Gd accumulates in brains of individuals with an age-dependent BBB breakdown and/or mild cognitive impairment remains unclear.METHODS:
We analyzed T1-weighted magnetic resonance imaging (MRI) scans from 52 older participants with BBB breakdown in the hippocampus 19-28 months after either cyclic or linear Gd agent.RESULTS:
There was no change in T1-weighted signal intensity between the baseline contrast MRI and unenhanced MRI on re-examination in any of the studied 10 brain regions with either Gd agent suggesting undetectable Gd brain retention.DISCUSSION:
Gd does not accumulate in brains of older individuals with a BBB breakdown in the hippocampus. Thus, Gd agents can be used without risk of brain retention within a â¼2-year follow-up to study BBB in the aging human brain in relation to cognition and/or other pathologies.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Magnetic Resonance Imaging
/
Blood-Brain Barrier
/
Cognitive Dysfunction
/
Gadolinium
/
Hippocampus
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Alzheimers Dement
Year:
2019
Document type:
Article
Affiliation country:
United States